A pooled analysis of the effect of condoms in preventing HSV-2 acquisition.
暂无分享,去创建一个
Amalia S Magaret | Anna Wald | A. Wald | L. Stanberry | E. Martin | A. Magaret | A. Langenberg | E. Krantz | M. Kamb | S. Gottlieb | Lawrence Stanberry | Sami L Gottlieb | Elizabeth Krantz | Mary Kamb | Emily T Martin | Andria Langenberg | Elizabeth M. Krantz
[1] Philip S. Yu,et al. Surveys of HIV-1, HTLV-I, and other sexually transmitted diseases in female sex workers in Taipei City, Taiwan, from 1993 to 1996. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[2] E. Lazcano-Ponce,et al. Sexual and Demographic Risk Factors for Herpes Simplex Virus Type 2 According to Schooling Level Among Mexican Youths , 2003, Sexually transmitted diseases.
[3] Lillian S. Lin,et al. Does Measured Behavior Reflect STD Risk?: An Analysis of Data From a Randomized Controlled Behavioral Intervention Study , 2000, Sexually transmitted diseases.
[4] Rebecca S Lewis,et al. Projected cancer risks from computed tomographic scans performed in the United States in 2007. , 2009, Archives of internal medicine.
[5] I. Brill,et al. Application of the case-crossover design to reduce unmeasured confounding in studies of condom effectiveness. , 2005, American journal of epidemiology.
[6] T. Mastro,et al. Herpes in the time of AIDS: a comparison of the epidemiology of HIV-1 and HSV-2 in young men in northern Thailand. , 1999, Sexually transmitted diseases.
[7] T. F. Rinke de Wit,et al. Herpes Simplex Virus Type 2 Seropositivity Among Urban Adults in Africa: Results From Two Cross-sectional Surveys in Addis Ababa, Ethiopia , 2002, Sexually transmitted diseases.
[8] A. Adimora,et al. Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group. , 1999, JAMA.
[9] M. Heywood. International Partnership against HIV / AIDS in Africa (IPAA) takes a major step forward. , 2000, AIDS analysis Africa.
[10] D R Holtgrave,et al. Design, measurement, and analytical considerations for testing hypotheses relative to condom effectiveness against non-viral STIs , 2002, Sexually transmitted infections.
[11] R. Redberg,et al. Cancer risks and radiation exposure from computed tomographic scans: how can we be sure that the benefits outweigh the risks? , 2009, Archives of internal medicine.
[12] C. Parker,et al. Herpes simplex virus type 2 infection among young uncircumcised men in Kisumu, Kenya , 2007, Sexually Transmitted Infections.
[13] G. Moneta,et al. Projected Cancer Risks From Computed Tomographic Scans Performed in the United States in 2007 , 2010 .
[14] Crosby Ra. Condom use as a dependent variable: measurement issues relevant to HIV prevention programs. , 1998 .
[15] D. Kleinbaum,et al. Condom effectiveness for reducing transmission of gonorrhea and chlamydia: the importance of assessing partner infection status. , 2004, American journal of epidemiology.
[16] M. Fishbein,et al. Incidence of herpes simplex virus type 2 infection in 5 sexually transmitted disease (STD) clinics and the effect of HIV/STD risk-reduction counseling. , 2004, The Journal of infectious diseases.
[17] A. Wald,et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. , 2001, JAMA.
[18] H. Ward,et al. Risky business: health and safety in the sex industry over a 9 year period. , 1999, Sexually transmitted infections.
[19] F Rhodes,et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group. , 1998, JAMA.
[20] E. Erbelding. Glycoprotein D-adjuvant vaccine to prevent genital herpes. , 2003, Current infectious disease reports.
[21] A. Wald,et al. Demographic rather than behavioral risk factors predict herpes simplex virus type 2 infection in sexually active adolescents , 2001, The Pediatric infectious disease journal.
[22] J. Carr,et al. Association of herpes simplex virus type 2 infection and syphilis with human immunodeficiency virus infection among men who have sex with men in Peru. , 2006, The Journal of infectious diseases.
[23] S. Kapiga,et al. Human Immunodeficiency Virus Type 1 Among Bar and Hotel Workers in Northern Tanzania: The Role of Alcohol, Sexual Behavior, and Herpes Simplex Virus Type 2 , 2006, Sexually transmitted diseases.
[24] B. Stray-Pedersen,et al. Decline in HIV prevalence among women of childbearing age in Moshi urban, Tanzania , 2007, International journal of STD & AIDS.
[25] G. Löwhagen,et al. Recurrent genital herpes in a population attending a clinic for sexually transmitted diseases. , 2001, Acta dermato-venereologica.
[26] Lawrence Corey,et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes* , 2004, The New England journal of medicine.
[27] A. Langenberg. Interrupting herpes simplex virus type 2 transmission: the role of condoms and microbicides. , 2004, Herpes : the journal of the IHMF.
[28] J. Hardin,et al. The validity of teens' and young adults' self-reported condom use. , 2009, Archives of pediatrics & adolescent medicine.
[29] C. Word,et al. The High‐Risk Sexual Practices of Crack‐Smoking Sex Workers Recruited From the Streets of Three American Cities , 1998, Sexually transmitted diseases.
[30] S. Weller,et al. The effectiveness of condoms in reducing heterosexual transmission of HIV. , 1999, Family planning perspectives.
[31] F. C. Martínez,et al. Sexually transmitted diseases in 1161 HIV‐positive patients: a 38‐month prospective study in southern Spain , 1998, Journal of the European Academy of Dermatology and Venereology : JEADV.
[32] K. Holmes,et al. Sentinel Surveillance of Sexually Transmitted Infections/HIV and Risk Behaviors in Vulnerable Populations in 5 Central American Countries , 2007, Journal of acquired immune deficiency syndromes.
[33] Fact Sheet for Public Health Personnel : Male Latex Condoms and Sexually Transmitted Diseases , 2002 .
[34] A. Wald,et al. Condom use and the prevention of genital herpes acquisition. , 2002, Herpes : the journal of the IHMF.
[35] M. Wong,et al. Seroprevalence of HSV-1 and 2 among sex workers attending a sexually transmitted infection clinic in Singapore , 2006, International journal of STD & AIDS.
[36] J. Parry,et al. How safe is safer sex? High levels of HSV-1 and HSV-2 in female sex workers in London , 2006, Epidemiology and Infection.
[37] M. Pitts,et al. Effects of a change from an appointment service to a walk-in triage service at a sexual health centre , 2003, International journal of STD & AIDS.
[38] David W. Hosmer,et al. Applied Survival Analysis: Regression Modeling of Time-to-Event Data , 2008 .
[39] H. Lipton. Home is where the health is: advancing team-based care in chronic disease management. , 2009, Archives of internal medicine.
[40] B. Kaplan. Coronary Artery Calcification Screening: Estimated Radiation Dose and Cancer Risk , 2010 .
[41] J. Klausner,et al. Predictors of incident herpes simplex virus type 2 infections in young women at risk for unintended pregnancy in San Francisco , 2007, BMC infectious diseases.
[42] L. Corey,et al. Risk Factors for the Sexual Transmission of Genital Herpes , 1992, Annals of Internal Medicine.
[43] D. Bernstein,et al. Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: a prospective couple study. , 1993, The Journal of infectious diseases.
[44] Linda H. Klieman,et al. Case management to reduce risk of cardiovascular disease in a county health care system. , 2009, Archives of internal medicine.
[45] K. Holmes,et al. Effectiveness of condoms in preventing sexually transmitted infections. , 2004, Bulletin of the World Health Organization.
[46] Diana B. Petitti,et al. Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis: Methods for Quantitative Synthesis in Medicine , 1994 .
[47] A. Wald. Herpes simplex virus type 2 transmission: risk factors and virus shedding. , 2004, Herpes : the journal of the IHMF.
[48] L. Corey. Increasing prevalence of HSV-2 points to need for more effective prevention strategies. , 2002, Herpes : the journal of the IHMF.
[49] Jeffrey D Dawson,et al. Physician and pharmacist collaboration to improve blood pressure control. , 2009, Archives of internal medicine.
[50] A. Ouedraogo,et al. Association between bacterial vaginosis and Herpes simplex virus type-2 infection: implications for HIV acquisition studies , 2007, Sexually Transmitted Infections.
[51] J. Douglas,et al. Comparison of Sexually Transmitted Disease Prevalence by Reported Condom Use: Errors Among Consistent Condom Users Seen at an Urban Sexually Transmitted Disease Clinic , 2004, Sexually transmitted diseases.
[52] Jasmine Jones,et al. Impact of a pharmacist-facilitated hospital discharge program: a quasi-experimental study. , 2009, Archives of internal medicine.
[53] S. Sanders,et al. Condom Use as a Dependent Variable: A Brief Commentary About Classification of Inconsistent Users , 2004, AIDS and Behavior.
[54] HIV spread in four sub-Saharan African cities. , 2000, AIDS analysis Africa.
[55] N. Muñoz,et al. Prevalence and Risk Factors for Herpes Simplex Virus Type 2 Infection Among Middle-Age Women in Brazil and the Philippines , 2001, Sexually transmitted diseases.
[56] J. Clay-Warner,et al. Assessing Condom Use Practices: Implications for Evaluating Method and User Effectiveness , 1998, Sexually transmitted diseases.
[57] Hyatt Dulles Airport. Scientific Evidence on Condom Effectiveness for Sexually Transmitted Disease (STD) Prevention , 2001 .
[58] M. Alter,et al. Incidence and Prevalence of Chlamydia, Herpes, and Viral Hepatitis in a Homeless Adolescent Population , 2001, Sexually transmitted diseases.
[59] A. Adimora,et al. The Relationship between Condom Use and Herpes Simplex Virus Acquisition , 2005, Annals of Internal Medicine.
[60] J. Kaldor,et al. Herpes simplex virus type 2 in prisoners, New South Wales, Australia , 2000, International journal of STD & AIDS.